| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non–small-Cell Lung Cancer
|
Dawe, David E.
|
|
2016
|
17 |
6 |
p. 563-572.e2
56638 p.
|
artikel
|
| 2 |
A Survival Score for Patients Receiving Palliative Irradiation for Locally Advanced Lung Cancer
|
Rades, Dirk
|
|
2016
|
17 |
6 |
p. 558-562
5 p.
|
artikel
|
| 3 |
Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non–Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group
|
Karampeazis, Athanasios
|
|
2016
|
17 |
6 |
p. 543-549
7 p.
|
artikel
|
| 4 |
Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer
|
Pore, Milind
|
|
2016
|
17 |
6 |
p. 535-542
8 p.
|
artikel
|
| 5 |
Circulating Biomarkers in Non–Small-Cell Lung Cancer: Current Status and Future Challenges
|
Matikas, Alexios
|
|
2016
|
17 |
6 |
p. 507-516
10 p.
|
artikel
|
| 6 |
Clinical Implications of Isolated Bone Failure Without Systemic Disease Progression During EGFR-TKI Treatment
|
Hwang, Ji An
|
|
2016
|
17 |
6 |
p. 573-580.e1
5228 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2016
|
17 |
6 |
p. A8-
1 p.
|
artikel
|
| 8 |
EGFR Testing in Advanced Non–Small-Cell Lung Cancer, A Mini-Review
|
Sheikine, Yuri
|
|
2016
|
17 |
6 |
p. 483-492
10 p.
|
artikel
|
| 9 |
Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non–Small-Cell Lung Cancer
|
Pollom, Erqi L.
|
|
2016
|
17 |
6 |
p. 588-594
7 p.
|
artikel
|
| 10 |
Incorporation of Antiangiogenic Therapy Into the Non–Small-Cell Lung Cancer Paradigm
|
Chu, Benjamin F.
|
|
2016
|
17 |
6 |
p. 493-506
14 p.
|
artikel
|
| 11 |
Management of Resistance to Crizotinib in Anaplastic Lymphoma Kinase-Positive Non–Small-cell Lung Cancer
|
Matikas, Alexios
|
|
2016
|
17 |
6 |
p. 474-482
9 p.
|
artikel
|
| 12 |
Optimizing Survival of Patients With Marginally Operable Stage IIIA Non–Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery
|
Yang, Kai-Lin
|
|
2016
|
17 |
6 |
p. 550-557
8 p.
|
artikel
|
| 13 |
Prognostic Factor Analysis in Patients With Small-Cell Lung Cancer Treated With Third-Line Chemotherapy
|
Saruwatari, Koichi
|
|
2016
|
17 |
6 |
p. 581-587
7 p.
|
artikel
|
| 14 |
Progression-Free and Overall Survival of Patients With ALK Rearrangement–Positive Non–Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib
|
Watanabe, Satomi
|
|
2016
|
17 |
6 |
p. 528-534
7 p.
|
artikel
|
| 15 |
Protocol Design for the Bench to Bed Trial in Alectinib-Refractory Non–Small-Cell Lung Cancer Patients Harboring the EML4-ALK Fusion Gene (ALRIGHT/OLCSG1405)
|
Isozaki, Hideko
|
|
2016
|
17 |
6 |
p. 602-605
4 p.
|
artikel
|
| 16 |
Stereotactic Body Radiotherapy for T3N0 Lung Cancer With Chest Wall Invasion
|
Berriochoa, Camille
|
|
2016
|
17 |
6 |
p. 595-601
7 p.
|
artikel
|
| 17 |
Table of Contents
|
|
|
2016
|
17 |
6 |
p. A14, A19-A20, A21
|
artikel
|
| 18 |
The Pharmacological Costs for the Management of Skin Toxicity in Patients With Cancer Treated With Epidermal Growth Factor Receptor-Inhibitors
|
Giuliani, Jacopo
|
|
2016
|
17 |
6 |
p. 471-473
3 p.
|
artikel
|
| 19 |
Treatment of Lung Cancer Patients With Actionable Mutations in the Intensive Care Unit
|
Kerrigan, Kathleen
|
|
2016
|
17 |
6 |
p. 523-527
5 p.
|
artikel
|
| 20 |
Yield and Clinical Utility of Next-Generation Sequencing in Selected Patients With Lung Adenocarcinoma
|
DiBardino, David M.
|
|
2016
|
17 |
6 |
p. 517-522.e3
521484 p.
|
artikel
|
Tijdschrift beschrijving